Similar Articles |
|
The Motley Fool December 2, 2004 W.D. Crotty |
Nothing to Pall Over Filtration, separation, and purification giant Pall reported an 11% increase in revenue for the first fiscal quarter. While Pall is the global leader in its markets, there is mounting competition from industrial giants. |
The Motley Fool December 14, 2011 Neha Chamaria |
Can Pall Stand Tall After an Impressive Quarter? Emerging markets play a positive role. |
The Motley Fool November 3, 2011 Keki Fatakia |
Should You Be Worried About Danaher? Danaher reports 46% higher revenues, but why are profits down? |
Chemistry World May 10, 2006 Katharine Sanderson |
Leading Lab Suppliers Merge Analytical instrument firm Thermo Electron and chemical manufacturer Fisher Scientific announced a merger, aiming to become the leading provider of laboratory products and services in the health sciences industry. |
The Motley Fool June 2, 2004 Bill Mann |
A Little Cloudy at Pall Purification and filtration giant Pall comes in a little light. |
The Motley Fool December 15, 2005 Tim Hanson |
The Best $17 Billion Company You Don't Know Contrary to popular belief, large caps can fly under the radar. Danaher is simply a conglomerate of boring companies that the world can't do without. Investors, take note. |
Chemistry World July 8, 2015 Phillip Broadwith |
Thermo Fisher to buy Alfa Aesar chemical supplies The acquisition complements its existing Fisher Scientific chemicals supply segment, and will be integrated with its laboratory products and services portfolio. |
The Motley Fool June 2, 2005 Stephen D. Simpson |
Pall's Play for Purity This filtration company faces near-term challenges, but its markets are poised for growth. Investors, take note. |
The Motley Fool September 14, 2006 Anders Bylund |
Margins Are Your Pals, Pall How will the filtration company revive flagging growth and thinning margins? Investors, take note. |
The Motley Fool February 7, 2008 Brian Orelli |
A Lab Match Made in Heaven The case of Thermo Electron and Fisher Scientific shows why mergers work. |
The Motley Fool December 15, 2008 Chris Jones |
Pall Falters, but Doesn't Fall Filter manufacturer Pall is a solid company with management that is prepared to guide it through the oncoming economic onslaught. |
The Motley Fool September 13, 2005 Stephen D. Simpson |
A Shadow on Pall While the water filtration company Pall is in some interesting and attractive business segments, I can't see any compelling reason to pay such a high price for the stock. |
Chemistry World January 8, 2014 Phillip Broadwith |
Thermo Fisher to sell three analytical divisions to GE Healthcare GE will take over Thermo's cell culture supplies, gene modulation and magnetic beads businesses, which are expected to generate combined sales in the region of $250 million for 2013. |
The Motley Fool May 8, 2006 Stephen D. Simpson |
Fisher Scientific Reels In a Deal A fair price and impressive market leverage give this merger between Fisher Scientific and Thermo Electron a better-than-average chance. Shareholders, take note. |
The Motley Fool December 7, 2005 Stephen D. Simpson |
Why Pay for Pall? Filtration is still a good business, but this firm's modest performance doesn't impress shareholders. |
The Motley Fool May 2, 2006 Stephen D. Simpson |
Still Fishing for Value at Fisher At the right price, this would be an interesting play on health care and biomedical research. Investors, take note. |
The Motley Fool October 26, 2007 Brian Orelli |
This Just In: Mergers Do Indeed Lower Costs As the anniversary integration between Thermo Electron and Fisher Scientific approaches next week, Thermo Fisher Scientific announced third-quarter results that demonstrated how the integration is having a nice effect on the bottom line. |
CIO July 27, 2012 Kim S. Nash |
How Thermo Fisher Mines Customer Feedback to Improve Service Thermo Fisher Scientific overhauled its customer feedback system to allow it to be more responsive to current customers and to take advantage of emerging markets |
The Motley Fool October 26, 2011 Tim Beyers |
Thermo Fisher Scientific Shares Plunged: What You Need to Know Shares of Thermo Fisher Scientific fell more than 10% in early trading and closed off almost that much after lowering full-year earnings and revenue guidance. |
The Motley Fool April 20, 2006 Stephen D. Simpson |
Will Danaher Break the Cycle? This diversified company seems to be moving toward less cyclical sensitivity. What does it mean for investors? |
The Motley Fool August 16, 2007 Brian Orelli |
More Drugmaker Growth Without the FDA All that high-tech lab equipment has to come from somewhere. Here's how investors can benefit from it, too. |
The Motley Fool April 27, 2009 Toby Shute |
The Industrial Elephant in the Room Danaher, the large conglomerate which makes everything from postal scanners to dental instruments, is far from a household name, but it is a name you should get to know. |
The Motley Fool July 20, 2006 Stephen D. Simpson |
More Blocking and Tackling From Danaher For those investors who lean toward quality over quantity, Danaher might be the ticket. |
Chemistry World April 19, 2013 Sarah Houlton |
Thermo Fisher to buy Life Technologies in $15.8bn deal Life Technologies specializes in research products, with a particular focus on genetic sequencing and DNA analysis. |
BusinessWeek January 22, 2007 Aaron Pressman |
Homeland Security 2.0 Five years after September 11, a new wave of smarter high-tech tools is coming to market. |
The Motley Fool June 2, 2006 Stephen D. Simpson |
Pall Still Looks Clogged Weak margins and poor returns on capital don't make for a compelling case for this leading player in filtration and separation equipment and technology. Investors, take note. |
The Motley Fool June 16, 2005 Stephen D. Simpson |
Clean Air for CLARCOR This business supplies all manner of filtration products for powered vehicles, though autos are not a major driver, and the slowdown in domestic auto sales isn't really hurting the business. But valuations are beginning to look a bit stretched, so investors need to tread carefully. |
The Motley Fool October 10, 2011 Alex Dumortier |
Don't Buy Into Pall's Share Buyback Purification and filtration products manufacturer Pall's new buyback program is no "buy" indicator. |
The Motley Fool November 9, 2005 Stephen D. Simpson |
Fishing for Value at Fisher Even with today's earnings-induced jump, there still might be some value here at researcher Fisher Scientific. Investors, take note. |
The Motley Fool July 21, 2005 Stephen D. Simpson |
Oh, Danny Boy ... Danaher has a bewildering array of businesses, but they've delivered growth so far. Annualizing the second quarter's results leaves you with a return on assets of more than 10% and a return on equity of close to 20% -- two hallmarks of well-run companies. Investors, take note. |